Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers
In Brief: Garb Raps “Hostility Of Executive Branch”; Hew Considers Allowing Grants For Industry
New Mexico CBCCP Charges Contracts Terminated for “Mundane Political, Economic” Factors
“Dog And Pony Show” At FCRF For NCAB OFF
Congress Asked To Equalize Cuts, Add $20 million For Centers
ACS Says New Tax Policy Hurts Charity Funds
Study Finds Short Term Tests Predict Carcinogenicity
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - As daraxonrasib hits the clinic, Frank McCormick says RAS is bigger than pancreatic cancer
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- Mount Sinai oncologist Krystal Cascetta, 40, and her infant daughter die in Somers, NY, home









